Breazu, C.M.; Maniu, A.A.; Marchis, I.F.; Negrut, M.F.; Ciocan, R.A.; Mihăileanu, F.V.; Necula, V.
Dexmedetomidine Continuous Infusion vs. Remifentanil Target-Controlled Infusion for Conscious Sedation in Otosclerosis Surgery—A Prospective, Single-Center, Randomized Controlled Trial. J. Clin. Med. 2025, 14, 2869.
https://doi.org/10.3390/jcm14092869
AMA Style
Breazu CM, Maniu AA, Marchis IF, Negrut MF, Ciocan RA, Mihăileanu FV, Necula V.
Dexmedetomidine Continuous Infusion vs. Remifentanil Target-Controlled Infusion for Conscious Sedation in Otosclerosis Surgery—A Prospective, Single-Center, Randomized Controlled Trial. Journal of Clinical Medicine. 2025; 14(9):2869.
https://doi.org/10.3390/jcm14092869
Chicago/Turabian Style
Breazu, Caius Mihai, Alma Aurelia Maniu, Ioan Florin Marchis, Matei Florin Negrut, Răzvan Alexandru Ciocan, Florin Vasile Mihăileanu, and Violeta Necula.
2025. "Dexmedetomidine Continuous Infusion vs. Remifentanil Target-Controlled Infusion for Conscious Sedation in Otosclerosis Surgery—A Prospective, Single-Center, Randomized Controlled Trial" Journal of Clinical Medicine 14, no. 9: 2869.
https://doi.org/10.3390/jcm14092869
APA Style
Breazu, C. M., Maniu, A. A., Marchis, I. F., Negrut, M. F., Ciocan, R. A., Mihăileanu, F. V., & Necula, V.
(2025). Dexmedetomidine Continuous Infusion vs. Remifentanil Target-Controlled Infusion for Conscious Sedation in Otosclerosis Surgery—A Prospective, Single-Center, Randomized Controlled Trial. Journal of Clinical Medicine, 14(9), 2869.
https://doi.org/10.3390/jcm14092869
